NUS
Nu Skin Enterprises, Inc.NYSEConsumer Defensive$7.41+0.68%ClosedMarket Cap: $356.6M
As of 2026-04-06
Valuation
P/E (TTM)
2.23
PEG
0.01
P/B
0.45
P/S
0.24
EV/EBITDA
1.83
DCF Value
$17.83
FCF Yield
12.9%
Div Yield
3.2%
Margins & Returns
Gross Margin
69.4%
Operating Margin
4.4%
Net Margin
10.8%
ROE
20.4%
ROA
12.5%
ROIC
4.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $370.3M | 70.7% | $23.2M | $14.5M | $0.29 | $0.06 |
| FY 2025 | $1.49B | 69.4% | $90.9M | $160.2M | $3.18 | $0.24 |
| Q3 2025 | $364.2M | 70.5% | $21.6M | $17.1M | $0.34 | $0.06 |
| Q2 2025 | $386.1M | 68.8% | $30.8M | $21.1M | $0.43 | $0.06 |
| Q1 2025 | $364.5M | 67.8% | $-9.9M | $107.5M | $2.14 | $0.06 |
| Q4 2024 | $445.6M | 62.7% | $-53.1M | $-36.1M | $-0.73 | $0.06 |
| FY 2024 | $1.73B | 68.2% | $-151.6M | $-146.6M | $-2.95 | $0.24 |
| Q3 2024 | $430.1M | 70.1% | $18.2M | $8.3M | $0.17 | $0.06 |
| Q2 2024 | $439.1M | 70.0% | $-125.6M | $-118.3M | $-2.38 | $0.06 |
| Q1 2024 | $417.3M | 70.5% | $8.8M | $-533.0K | $-0.01 | $0.06 |
| Q4 2023 | $488.6M | 72.1% | $16.1M | $7.3M | $0.15 | $0.39 |
| FY 2023 | $1.97B | 68.9% | $48.3M | $8.6M | $0.17 | $1.56 |